15 Stocks Moving in Friday’s Pre-Market Session
Gainers
Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) rose 42% to $3.21 in pre-market trading.
AbCellera Stock Is Moving Higher After Expanded Use Nod For Lilly-Partnered COVID-19 Antibody
The FDA has expanded the Emergency Use Authorization (EUA) for bamlanivimab 700 mg and etesevimab 1400 mg administered together to…
AbCellera Biologics Reports FDA Emergency Use Authorization for Its Bamlanivimab, Etesevimab Administered Together Expanded To Include Post-Exposure Prophylaxis For COVID-19; Same News As Eli Lilly Earlier
AbCellera (NASDAQ:ABCL) today announced the U.S. Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) for bamlanivimab (LY-CoV555) 700 mg administered with etesevimab (LY-CoV016)
AbCellera Shares Are Moving Higher On Licensing Pact With Moderna
AbCellera Biologics Inc (NASDAQ:ABCL) has entered into a research collaboration and license agreement with Moderna Inc (NASDAQ:MRNA) for antibodies for mRNA medicines. The…
78 Biggest Movers From Friday
Gainers
PharmaCyte Biotech, Inc. (NASDAQ: PMCB) shares jumped 43.4% to close at $3.27. PharmaCyte Biotech recently reported closing of $15-million public offering.
Credit Suisse Maintains Outperform on AbCellera Biologics, Lowers Price Target to $49
Credit Suisse analyst Tiago Fauth maintains AbCellera Biologics (NASDAQ:ABCL) with a Outperform and lowers the price target from $51 to $49.
The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 11)
Earnings Scheduled For August 12, 2021
Companies Reporting Before The Bell
• Anavex Life Sciences (NASDAQ:AVXL) is estimated to report earnings for its third quarter.
The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight
Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in, triggering stock-specific moves, while clinical readouts also moved stocks during the week.